Health Canada Shortened Your Device Import Window to 3 Days: What Changed September 2

If your company imports foreign-authorized medical devices to help fill a Canadian shortage, the process you followed last month may no longer be compliant. On September 2, 2026, Health Canada updated the two forms that govern exceptional importation and sale of medical devices, FRM-0577 and FRM-0578. The changes look administrative at first glance, but one of them shortens a deadline that sits at the heart of your shipping process, and another adds a document you must have on file before you submit.

The update arrived as a compliance bulletin rather than a headline announcement, so it is easy to miss. That is exactly what makes it risky. A team still working from a five business day notification clock, or still using the old PDF forms, can fall out of step with Health Canada without realizing anything changed. This article explains what changed on September 2, 2026, why exceptional importation exists, how the two forms differ, and the practical steps to bring your standard operating procedures back into line.

Executive Summary

Exceptional importation lets Health Canada allow the sale of a foreign-authorized medical device that is not licensed in Canada, so patients keep access to critical devices during a shortage. The September 2, 2026 update modernizes the forms and tightens the timeline. The headline points for a compliance lead:

What changed: FRM-0577 and FRM-0578 moved from PDF to web forms, effective September 2, 2026.
The deadline: the notification window before a shipment arrives at a Canadian port of entry shortened from five business days to three.
New evidence: FRM-0577 now requires proof of a valid quality management system (QMS) certification held by the manufacturer.
Who is affected: importers and distributors requesting exceptional access to foreign-authorized devices during shortages.
What to do now: update your SOPs to the three day clock, collect manufacturer QMS certificates in advance, and switch your team to the web forms.

What Changed on September 2, 2026?

Health Canada updated the two exceptional-importation device forms, FRM-0577 and FRM-0578, effective September 2, 2026. As set out in the compliance bulletin, the forms moved from PDF to web forms, the notification window shortened from five business days to three, and FRM-0577 now asks for proof of the manufacturer's valid QMS certification. The requirements themselves are not brand new, but the timeline and the evidence expectations are stricter, and the submission method is different.

The web forms let you attach supporting files in common formats, including JPG or JPEG, PNG, DOC or DOCX, XLSX, GIF, and PDF. FRM-0578 now also asks for the lot number and expiry date of the imported devices. Both forms carry attestations covering distribution records, complaint handling, incident reporting, disclosure of safety information, and recall procedures. The table below compares the old process with the new one.

Element	Before	From September 2, 2026
Form format	PDF forms	Web forms with file attachments
Notification window	Five business days before arrival	Three business days before arrival
Manufacturer QMS proof (FRM-0577)	Not explicitly required	Valid QMS certification required
Lot and expiry data (FRM-0578)	Not explicitly captured	Lot number and expiry date required
Attestations	Distribution, complaints, incidents, safety, recall	Distribution, complaints, incidents, safety, recall

What Is Exceptional Importation of Medical Devices?

Exceptional importation is a shortage tool. It lets Health Canada permit the importation and sale of a specific foreign-authorized medical device that is not licensed in Canada, when a shortage could put patients at risk. Health Canada maintains a public List of medical devices for exceptional importation and sale, and a device must be added to that List before it can be imported and sold under this pathway. The device is authorized in a trusted foreign jurisdiction, so the safeguard is oversight and record keeping rather than a full Canadian licence.

The pathway began during the COVID-19 period and was made a permanent option through regulations that came into force on March 2, 2022, which built exceptional importation into the framework of the Medical Devices Regulations (SOR/98-282). It sits alongside the shortage reporting duties that already apply to certain devices, and it does not replace a manufacturer's obligation to seek a proper Medical Device Licence for the longer term.

FRM-0577 and FRM-0578: How the Two Forms Differ

The two forms do different jobs, and mixing them up is a common source of delay. FRM-0577 is the proposal to add a foreign-authorized device to the List. FRM-0578 is the notification you file when you are about to import and sell a device that is already on the List. In short, one gets the device onto the List, and the other tells Health Canada a specific shipment is coming. The table sets out the split.

Form	Purpose	Key new expectation
FRM-0577	Propose adding a foreign-authorized device to the List	Foreign regulator name, shortage justification, importation end dates, unit quantities, and valid manufacturer QMS certification
FRM-0578	Notify Health Canada of an exceptional importation and sale	Lot number and expiry date, filed at least three business days before arrival

The New QMS Certification Requirement

The addition of a manufacturer QMS certification requirement to FRM-0577 matters because it moves a piece of evidence upstream. You now need proof that the foreign manufacturer holds a valid quality management system certification before you can propose adding the device to the List. For most higher-risk devices this means a valid ISO 13485 certificate or an equivalent recognized certification, matching the quality expectation Health Canada applies elsewhere in the device framework.

The practical trap is timing. QMS certificates expire, and getting a current copy from a foreign manufacturer can take days or weeks. If you wait until a shortage is urgent, you may not have the certificate in hand when you need it. This is the same discipline that underpins Health Canada's recognized standards approach for medical devices: current, verifiable evidence of quality, ready before you file.

Why the Three Day Window Is a Process Risk

The shortened notification window is the change most likely to catch a compliant company off guard. A firm that built its shipping and logistics steps around a five business day clock now has two fewer days to notify Health Canada before a shipment reaches a Canadian port of entry. If the internal SOP still says five days, the team is not just slower than the new rule allows. It is following a procedure that no longer matches the regulator's expectation, which is exactly the kind of gap an inspection or a records request will surface.

There is also a quieter risk. Because the update was published as a compliance bulletin, many teams will never see a press release about it. The people most exposed are the ones doing everything else right, because their confidence in an established, documented process is precisely what stops them from checking whether the rule moved. A short internal review now is far cheaper than a missed notification later.

A Practical Example: When the Clock Catches a Good Team

Consider a distributor that has held an exceptional-importation authorization for two years and has a clean record. Their written procedure, built in 2024, tells the logistics coordinator to file the notification five business days before a shipment lands. In practice they often file six or seven days ahead, so on paper they look comfortable. After September 2, 2026, that comfort is misleading. The regulator now expects notice three business days out, and the procedure that once looked conservative now describes a slower internal trigger than the rule assumes. During a records request, an inspector does not see a fast team. They see a standard operating procedure that no longer matches the current requirement, and they ask why it was not updated when the forms changed.

The corrective and preventive action here is a useful model for any regulatory change. First, correct the immediate gap: revise the SOP to the three business day clock and reissue it under document control with a clear effective date. Second, address the root cause, which is that the team had no trigger to review procedures when Health Canada updates a form. A simple preventive action is to assign someone to monitor the medical devices compliance bulletins and to log each change against the affected SOPs. Third, verify the fix by confirming through the next filing that the new timeline works in practice and that staff were trained and the training recorded. This is exactly the kind of closed-loop CAPA that inspectors look for, and it turns a quiet rule change into evidence that your quality system works.

Record Keeping That Holds Up Later

The new lot number and expiry date fields on FRM-0578 are not busywork. When a foreign-authorized device later becomes the subject of a complaint, an incident report, or a recall, those two data points are what let you find every affected unit quickly. A distributor that captures lot and expiry at the point of import, links them to its distribution records, and keeps them retrievable can answer Health Canada in hours rather than days. A distributor that treats the fields as a form to be filled and forgotten will struggle when it matters most. Treat the data you enter on these forms as the backbone of your recall readiness, not as a box to tick.

Compliance Checklist

Update every exceptional-importation SOP to the three business day notification clock.
Switch your team from the old PDF forms to the current FRM-0577 and FRM-0578 web forms.
Collect and store current manufacturer QMS certificates, such as ISO 13485, before a shortage arises.
Capture lot numbers and expiry dates for every imported device as a standing data field.
Confirm you can meet each attestation: distribution records, complaint handling, incident reporting, safety disclosure, and recall procedures.
Keep the foreign regulator name, shortage justification, importation end dates, and unit quantities ready for FRM-0577.
Train logistics and regulatory staff on the new timeline and forms, and record the training.

Common Mistakes to Avoid

Running on the old five day clock. An SOP that still says five business days now conflicts with the September 2, 2026 requirement.
Leaving the QMS certificate to the last minute. A missing or expired manufacturer certificate can stall a FRM-0577 proposal during a shortage.
Confusing the two forms. FRM-0577 adds a device to the List; FRM-0578 notifies a specific shipment. Filing the wrong one wastes time.
Treating exceptional importation as permanent. It is a shortage measure with end dates, not a substitute for a Medical Device Licence.
Weak lot and expiry tracking. Without clean lot and expiry data, a recall or incident report becomes far harder to manage.

Frequently Asked Questions

What is the new notification window for exceptional importation of medical devices?

As of September 2, 2026, you must notify Health Canada at least three business days before the shipment arrives at a Canadian port of entry, using FRM-0578. This replaced the previous five business day window.

What is the difference between FRM-0577 and FRM-0578?

FRM-0577 is the proposal to add a foreign-authorized device to Health Canada's List of medical devices for exceptional importation and sale. FRM-0578 is the notification you file when you are about to import and sell a device that is already on the List.

Do I need proof of the manufacturer's QMS certification?

Yes. FRM-0577 now requires proof of a valid quality management system certification held by the manufacturer. For most devices this means a current ISO 13485 certificate or an equivalent recognized certification, and it should be on file before you submit.

Are the old PDF forms still accepted?

Health Canada moved these submissions to web forms as of September 2, 2026. Your team should use the current web forms and confirm the accepted attachment formats, which include JPG or JPEG, PNG, DOC or DOCX, XLSX, GIF, and PDF.

Does exceptional importation replace a Medical Device Licence?

No. Exceptional importation is a temporary shortage measure with defined end dates. If you plan to sell a device in Canada over the longer term, you still need to pursue a proper Medical Device Licence and the related establishment requirements.

Who does this change apply to?

It applies to importers and distributors requesting exceptional access to foreign-authorized medical devices during a shortage. If your organization holds exceptional-importation authorizations or expects to use this pathway, the new forms and timeline apply to you.

How MFLRC Can Help

MF License and Regulatory Consultants (MFLRC) helps device importers and distributors keep their shortage-response processes compliant. We update SOPs to the new timeline, build the evidence files the forms now demand, and make sure your quality system can support an exceptional importation without last-minute scrambling. If you also manage drug shortages, our guide to the drug exceptional importation pathway is a useful companion, and for long-term market access we support the full Class III and IV medical device licence application process.

Where we help most:

SOP audits and updates to bring exceptional-importation procedures in line with the three day clock and web forms.
Gap assessments of your MDEL and shortage-response documentation against current Health Canada expectations.
QMS and supplier evidence support so manufacturer certifications and records are current and ready to attach.
Inspection readiness so your records, attestations, and recall procedures hold up under review.

Need help bringing your device import process in line with the September 2 changes? Contact MFLRC for expert guidance tailored to your shortage-response operations.

Book a Consultation

Conclusion

The September 2, 2026 update is small in wording and large in effect. A two day cut to a notification window, a new certificate to collect, and a switch to web forms are the kind of changes that quietly break an otherwise solid process. Treat this as a prompt to review your exceptional-importation SOPs, your QMS evidence files, and your device recall and reporting procedures, so that when a shortage hits you are ready to move at the pace Health Canada now expects.

The companies that stay compliant here are the ones that update their procedures before they need them. A short review today protects patient access and keeps your shortage response defensible tomorrow.